Evidence map›Paper›PMID 30841779›Full record

ReviewJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2019

Angiogenesis in the ischemic core: A potential treatment target?

Masato Kanazawa, Tetsuya Takahashi, Masanori Ishikawa, Osamu Onodera, Takayoshi Shimohata, Gregory J Del Zoppo

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 150 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. NFAT1Cellular & molecular biology letters · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Masato Kanazawa1 Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.ORCID 0000-0001-6337-8156
Tetsuya Takahashi1 Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.
Masanori Ishikawa1 Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.
Osamu Onodera1 Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.ORCID 0000-0003-3354-5472
Takayoshi Shimohata2 Department of Neurology and Geriatrics, Gifu University Graduate School of Medicine, Gifu, Japan.
Gregory J Del Zoppo3 Department of Medicine (Division of Hematology), University of Washington, Seattle, WA, USA.
Niigata University · JPGifu University · JPUniversity of Washington · US

Funding

Neurovascular Adhesion Receptors and Barrier IntegrityR01NS053716 · NINDS · UNIVERSITY OF WASHINGTON · PI DEL ZOPPO, GREGORY J · 2006 to 2016
$3.5M
Endothelial Beta 1-integrins in Cerebral Vascular Barrier IntegrityR01NS113393 · NINDS · UNIVERSITY OF WASHINGTON · PI DEL ZOPPO, GREGORY J · 2020 to 2023
$2.1M
MATRIX METALLOPROTEINASES AND NEURONS IN FOCAL ISCHEMIAR01NS038710 · NINDS · SCRIPPS RESEARCH INSTITUTE · PI DEL ZOPPO, GREGORY J · 1999 to 2002
$1.5M
Endothelial Beta 1-integrins in Cerebral Vascular Barrier IntegrityR56NS113393 · NINDS · UNIVERSITY OF WASHINGTON · PI DEL ZOPPO, GREGORY J · 2019 to 2019
$554k
NINDS NIH HHS R01 NS038710NINDS NIH HHS R01 NS053716NINDS NIH HHS R01 NS113393NINDS NIH HHS R56 NS113393
6 · The paper itself

Abstract

The ischemic penumbra is both a concept in understanding the evolution of cerebral tissue injury outcome of focal ischemia and a potential therapeutic target for ischemic stroke. In this review, we examine the evidence that angiogenesis can contribute to beneficial outcomes following focal ischemia in model systems. Several studies have shown that, following cerebral ischemia, endothelial proliferation and subsequent angiogenesis can be detected beginning four days after cerebral ischemia in the border of the ischemic core, or in the ischemic periphery, in rodent and non-human primate models, although initial signals appear within hours of ischemia onset. Components of the neurovascular unit, its participation in new vessel formation, and the nature of the core and penumbra responses to experimental focal cerebral ischemia, are considered here. The potential co-localization of vascular remodeling and axonal outgrowth following focal cerebral ischemia based on the definition of tissue remodeling and the processes that follow ischemic stroke are also considered. The region of angiogenesis in the ischemic core and its surrounding tissue (ischemic periphery) may be a novel target for treatment. We summarize issues that are relevant to model studies of focal cerebral ischemia looking ahead to potential treatments.

Indexed as

Cerebrovascular CirculationNeovascularization, PhysiologicAnimalsBrainBrain IschemiaHumansNeurogenesisVascular Remodelingangiogenesisaxonal outgrowthischemic coreIschemic penumbraremodeling

Identifiers

PMID30841779
PMCPMC6501515
OpenAlexW2920941908

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.